Glucosyl Hesperidin Supplementation Prevents Tubulointerstitial Fibrosis and Immune Activation in Diabetic Nephropathy in Mice
Nutrients · 2025
DOI: 10.3390/nu17030383 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Kotaro Hashimoto und 10 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Integrated Sciences for Life, Hiroshima University, Hiroshima 739-8528, Japan. Hauptthemen laut MEDLINE: Hesperidin, Diabetic Nephropathies, Dietary Supplements, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Diabetic nephropathy (DN) is a serious condition that can result in end-stage renal failure. Recent evidence has focused on the dietary effects of polyphenols on blood glucose levels and the complications of diabetes.
Objectives
In this study, we investigated the protective effect of glucosyl hesperidin (G-Hes), composed of glucose and hesperidin, against streptozotocin (STZ)-induced nephropathy in mice.
Methods
We used an STZ-induced diabetic mouse model to investigate the preventive effect of G-Hes on renal pathology. After G-Hes supplementation for 4 weeks, we investigated the renal gene expression profiles using DNA microarray analysis and renal histology to examine the underlying molecular mechanism.
Results
G-Hes suppressed the increase in kidney weight without any change in the blood glucose levels. This study identified 511 genes whose expression levels were substantially increased during DN development but were downregulated by G-Hes supplementation. G-Hes prevented mRNA expression associated with renal tubule injury, fibrosis, and immune responses. Notably, G-Hes supplementation considerably decreased the complement component C3 at the mRNA and protein levels in the glomeruli and ameliorated glomerular and mesangial matrix expansion in diabetic nephropathy.
Conclusions
G-Hes supplementation is useful in preventing tubulointerstitial fibrosis and inflammation in a mouse model of DN, without exhibiting a hypoglycemic effect.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate School of Integrated Sciences for Life, Hiroshima University, Hiroshima 739-8528, Japan.
ORCID-Profile: Rahmawati Aisyah, Seiji Kawamoto, Thanutchaporn Kumrungsee, Noriyuki Yanaka
Zitieren
APA
Hashimoto, K., Yoshida, Y., Kamesawa, M., Yazawa, N., Tominaga, H., Aisyah, R., Chen, S., Bumrungkit, C., Kawamoto, S., Kumrungsee, T., & Yanaka, N. (2025). Glucosyl Hesperidin Supplementation Prevents Tubulointerstitial Fibrosis and Immune Activation in Diabetic Nephropathy in Mice. Nutrients. https://doi.org/10.3390/nu17030383
Vancouver
Hashimoto K, Yoshida Y, Kamesawa M, Yazawa N, Tominaga H, Aisyah R, et al. Glucosyl Hesperidin Supplementation Prevents Tubulointerstitial Fibrosis and Immune Activation in Diabetic Nephropathy in Mice. Nutrients. 2025. doi:10.3390/nu17030383
BibTeX
@article{Hashimoto2025,
author = {Hashimoto, Kotaro and Yoshida, Yuki and Kamesawa, Mion and Yazawa, Nao and Tominaga, Hikaru and Aisyah, Rahmawati and Chen, Siyi and Bumrungkit, Chanikan and Kawamoto, Seiji and Kumrungsee, Thanutchaporn and Yanaka, Noriyuki},
title = {Glucosyl Hesperidin Supplementation Prevents Tubulointerstitial Fibrosis and Immune Activation in Diabetic Nephropathy in Mice},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17030383}
}
EUVIMED